Global and regional estimates of the morbidity due to type I diabetes among children aged 0-4 years:a systematic review and analysis by Adeloye, Davies et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Global and regional estimates of the morbidity due to type I
diabetes among children aged 0-4 years
Citation for published version:
Adeloye, D, Chan, KY, Thorley, N, Jones, C, Johnstone, D, L'Heveder, A, Saftic, V, Henderson, D, Chopra,
M, Campbell, H & Rudan, I 2018, 'Global and regional estimates of the morbidity due to type I diabetes
among children aged 0-4 years: a systematic review and analysis' Journal of Global Health, vol. 8, no. 2, pp.
021101. DOI: 10.7189/jogh.08.021101
Digital Object Identifier (DOI):
10.7189/jogh.08.021101
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Journal of Global Health
Publisher Rights Statement:
This work is licensed under a Creative Commons Attribution 4.0 International License.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
www.jogh.org •  doi: 10.7189/jogh.08.021101 1 December 2018  •  Vol. 8 No. 2 •  021101
V
IE
W
PO
IN
TS
RE
SE
A
RC
H
 T
H
E
M
E
 7
: E
PI
D
E
M
IO
LO
G
Y 
O
F 
 
N
O
N
-C
O
M
M
U
N
IC
A
B
LE
 C
A
U
SE
S 
O
F 
C
H
IL
D
 D
E
A
TH
S
Davies Adeloye1, Kit Yee Chan1, 
Natasha Thorley1, Charlotte 
Jones1, David Johnstone1,  
Ari L’Heveder1, Vanja Saftic2,3, 
David Henderson1, Mickey 
Chopra4, Harry Campbell1,  
Igor Rudan1
1  Centre for Global Health Research and World 
Health Organization’s Collaborating Centre for 
Population Health, Research and Training, The 
Usher Institute, University of Edinburgh, UK
2  Child and Youth Protection Center of Zagreb, 
Croatia
3  Croatian Catholic University, Zagreb, Croatia
4  The World Bank Group, Washington, D.C., 
USA
Correspondence to:
Professor Igor Rudan 
Chair in International Health and Molecular 
Medicine 
Joint Director, Centre for Global Health 
Research and WHO Collaborating Centre for 
Population Health Research and Training 
Director of Research, The Usher Institute for 
Population Health Sciences and Informatics 
The University of Edinburgh 
MacKenzie House 
30 West Richmond Street 
Edinburgh EH8 9DX 
Scotland, UK 
Igor.Rudan@ed.ac.uk
Global and regional estimates of the morbidity 
due to type I diabetes among children aged 0-4 
years: a systematic review and analysis
Background Epidemiology of type 1 diabetes mellitus (T1DM) among 
children aged 0-4 years globally is not well understood. We aim to 
assess the incidence of T1DM in low- and middle-income countries 
(LMIC) by conducting a systematic review of previous reports. We also 
aim to address possible contribution to child mortality and to identify 
any temporal trends.
Methods A systematic review was performed using a carefully designed 
search strategy to explore MEDLINE, EMBASE and Global Health da-
tabases. Data was extracted from all studies that satisfied the inclusion 
criteria –a total of 83 records extracted from 26 830 sources that were 
analysed. We used the Grading of Recommendations Assessment, De-
velopment and Evaluation (GRADE) process to assess quality of evi-
dence and applied meta-analysis approaches to assess global and re-
gional incidence and time trends.
Results The overall pooled incidence of T1DM in children aged 0-4 
years globally is 11.2 (95% CI = 10.0-12.3) per 100 000 child years. The 
regional incidence were the highest for European Region A (EUR A) at 
15.5 (95% CI = 13.5-17.5) per 100 000 child years. EUR C had the in-
cidence of 10.0 (95% CI = 6.5-13.6) and EUR B 5.8 (95% CI = 4.7-7.0), 
Region of the Americas A (AMR A) 11.4 (95% CI = 7.8-14.9), AMR B 
of 2.5 (95% CI = 0.2-4.8), Eastern Mediterranean Region (EMR B) 7.1 
(95% CI = 4.2-10.0) and Western Pacific Region (WPR A) 7.0 (95% 
CI = 2.9-11.0) per 100 000 child years, while other regions had very 
low rates or no data. When data points were categorised in the study 
periods and re-analysed, an increasing trend of the T1DM incidence 
was observed, with the incidence of 20.9 (95% CI = 7.8-34.1) per 
100 000 child years in the years 2010-2015, preceded by 13.2 (95% 
CI = 11.0-15.5) in 2000-2009 study period, 10.0 (95% CI = 8.4-11.7) 
in 1990-1999 and 8.3 (95% CI = 5.1-11.6) in 1980-1989, respectively. 
Although the data are scarce, and variation and uncertainty are large, 
we estimated that the number of new cases of T1DM among children 
aged 0-4 years in the world each year is between 100 000 and 150 000.
Conclusions The identified large variation in incidence estimates for 
different parts of the world, along with scarcity of information and the 
identified strong temporal increase in T1DM incidence suggest a clear 
need for further research into this subject.
Electronic supplementary material: 
The online version of this article contains supplementary material.
journal of
health
global
The epidemiology of type 1 diabetes mellitus (T1DM) is increasingly stud-
ied across several world regions to provide better understanding of the 
disease in these settings and prompt relevant public health and policy re-
sponse [1,2]. According to the International Diabetes Federation (IDF) 
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atlas, about 151 million people were estimated to have any type of diabetes globally in 2000 [3], 194 
million in 2003 [4], 246 million in 2006 [5], 415 million in 2015 and a projected increase to 642 mil-
lion by 2040 [6,7]. Mortality from diabetes globally increased from 16.3/100 000 to 19.5/100 000, and 
disability adjusted life years (DALYs) also increased from 523/100 000 to 680/100 000 between 1990 and 
2015 respectively [8,9].
T1DM remains a large public health concern globally, especially due to fast rising and varying incidence 
reported across diverse population groups [10]. According to the WHO Multinational Project for Child-
hood Diabetes (DiaMond) Research Group, overall age-adjusted incidence of T1DM varied from 0.1 in 
China and Venezuela to 37 per 100 000 person-years in Sardinia and in Finland, accounting for over 350-
fold difference in the T1DM incidence in about a hundred different populations of children aged 0-14 
years studied worldwide in early 1990s [11]. Experts have reported that this marked variation may reflect 
the heterogeneity within and between major ethnic populations globally [12,13], which possibly account 
for the hereditary and genetic factors indicated in the aetiology of T1DM. For example, T1DM incidence 
was reported to be higher among populations of white European ancestry, as observed in Nordic popu-
lations of Finland, Sweden, and Norway compared to other world regions [11]. In Israel, marked ethnic 
variations were observed, especially between Jewish and Arab populations [11]. In Africa, geographical 
and ethnic variations were observed in some populations in Tanzania, Nigeria, South Africa, and Ethio-
pia [14-16]. Although, genetic factors have been indicated in the development of T1DM, it is important 
to note that the aetiology is actually multifactorial, for which several theories have been suggested [17].
Meanwhile, increasing incidence and mortality from T1DM has been reported in children and adoles-
cents, especially in Central America, West Indies and several European countries [13]. A statistically sig-
nificant increase in T1DM incidence of 65% was noted in all the population that were studied, mostly in 
the younger age groups [18]. In Europe, annual increment in incidence of T1DM in children ranged from 
0.6%-15% across the 36 EURODIAB centres in the period 1989-2003 [10]. Moreover, in the US multi-
centre Search for Diabetes in Youth Study (SEARCH), there was marked annual increase in the incidence 
of T1DM in non-Hispanic White younger than 14 years, with a mean of 27.5 per 100 000 per year [19].
Patterson and colleagues provided worldwide estimates of T1DM in children aged 0-14 years, and high-
lighted challenges in the collation of epidemiological reports on T1DM in this age group [12]. There are 
currently few reports on deaths from T1DM, especially from Africa and many low- and middle-income 
countries (LMICs) [20]. Major causes of deaths have been linked to poor diagnosis and treatment, with 
many presenting with acute complications, infections, cardiovascular diseases and chronic kidney diseas-
es [2], with many calling for improved and continuous strategies for disease prevention, diagnosis and 
treatment on a population-wide scale [21]. In fact, speculations were reported hypothesising that T1DM 
could perhaps explain a major part of the unclassified causes of 0-14 years mortality in many low-resource 
settings [22]. In the light of the relatively poor understanding of the burden of T1DM in LMICs, especial-
ly among children under five years, this study aimed to review available evidence on T1DM in children 
aged 0-4 years globally in order to contribute to the understanding of the epidemiology, and provide im-
proved estimate of the incidence of the disease in this age group.
METHODS
Search strategy
After identification of relevant Medical Subject Headings (MESH) and keywords, a final search strategy 
was developed. Searches were conducted on three main databases: Medline, EMBASE and Global Health. 
Literature searches were conducted on 15 August 2018. The search date was set from January 1980 to 
date (Tables S1-S3 in Online Supplementary Document).
Selection criteria
We included i) studies published from 1980 to 2017 globally that referred to diabetes among children, 
ii) studies that directly attempted to estimate the prevalence, incidence and/or under-five mortality from 
T1DM across various world regions, and iii) studies that provided information that helps to understand 
the determinants of the occurrence and aetiology, clinical features, management, case-fatality rates, and 
outcomes of T1DM in children.
We excluded i) studies that are reviews, viewpoints and commentaries, iii) studies that do not report rel-
evant denominators from which prevalence, incidence and/or under-five mortality from T1DM can be 
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estimated, iv) studies with ambiguous study designs and analysis, v) studies without active follow-up pe-
riods, and vi) studies with case definitions not clearly defined and consistently applied.
Case definitions
In this review, we included studies that clearly reported T1DM diagnosis (based on registries and a clinical 
diagnosis of type 1 diabetes). Case definitions employed across studies varied, including the WHO criteria 
[23,24], the American Diabetic Association (ADA) criteria [25,26], and the WHO-IDF recommendation 
diagnosis of diabetes [27]. The final case definitions employed in the selection criteria were as follows:
  i. Fasting plasma glucose level at or above 7.0 mmol/L (126 mg/dL);
iii. Symptoms of hyperglycemia and casual plasma glucose at or above 11.1 mmol/L (200 mg/dL).
iii)  Glycated hemoglobin (hemoglobin A1C) at or above 48 mmol/mol (≥ 6.5 Diabetes Control and 
Complications Trial DCCT % [28] (Table 1).
Quality criteria and grading
Quality of individual studies was assessed based on the following criteria:
  i.  Study design: Under this, flaws in the design and execution of study were examined. Basically, this 
assesses methods of estimation of sample size and sampling methods across studies (if necessary), 
and the methods of dealing with design specific issues such as: training of study investigators, 
adherence to standardized protocol and case definitions/ascertainment for determining T1DM
ii.  Study analysis: This assesses the appropriateness of statistical and analytical methods employed 
across studies;
iii.  Study limitations: This assesses if the study explicitly stated the limitations, as this may further 
guide in the choice of selection; and
iv.  Generalizability to a larger population: This broadly assesses if the sample size or study popula-
tion was representative of a larger population in the region of study.
For the quality grading, the Grading of Recommendations Assessment, Development and Evaluation 
(GRADE) guidelines [29] were adapted:
  i.  High-quality: Studies with all four criteria, or any three including “study design” highlighted 
above, well represented;
 ii.  Moderate-quality: Studies with any three of the four criteria, or any two including “study design” 
highlighted above, well represented;
iii.  Low-quality: Studies with any two of the four criteria or “study design” only, highlighted above, 
well represented; and
iv.  Very low-quality: Studies with only one (excluding “study design”) or none of the four criteria 
highlighted above, well represented.
As a basic rule, all studies that were graded as high and moderate quality were included in the quantita-
tive analysis. Some low-quality studies were also included in the quantitative analysis on the basis of good 
study designs, and details of these studies will be described further in the discussion section. However, 
all very low-quality studies have been excluded.
Table 1. Diagnostic criteria for diabetes*
Condition (Unit) CasUal glUCose  
mmol/l(mg/dl) Fasting glUCose mmol/l(mg/dl) Hba1C (mmol/mol) dCCt %
Normal <7.8 (<140) <6.1 (<110) <42 <6.0
Impaired fasting glycaemia <7.8 (<140) ≥6.1(≥110) &<7.0(<126) 42-46 6.0–6.4
Impaired glucose tolerance ≥7.8 (≥140) <7.0 (<126) 42-46 6.0–6.4
Diabetes mellitus ≥11.1 (≥200) ≥7.0 (≥126) ≥48 ≥6.5
mmol/l(mg/dl) – millimoles per litre (milligrams per decilitre), HbA1
c
 – Hemoglobin A1c, DCCT – Diabetes Control and Compli-
cations Trial.
*Source: [24-28].
Adeloye et al.
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Data extraction
To allow for consistency, parallel searches were conducted following a predesigned guideline. Disagree-
ments in study selections were resolved by consensus. Data were abstracted systematically on period of 
study, location, study population, mean age or age range, number of T1DM cases, incidence, prevalence 
(if reported), and number of deaths from T1DM (if reported). All data were categorised by the World 
Health Organization (WHO) regions and study periods for further analysis. For studies conducted on 
the same study site, population or cohort, the first chronologically published study was selected, and all 
additional data from other studies were included in the selected paper.
Data analysis
A random-effects meta-analysis (DerSimonian and Laird method) was conducted on extracted crude inci-
dence rates [30]. This was reported separately for the WHO regions and study periods, all expressed per 
100 000 child years (population data were as reported in studies). Standard errors were determined from 
the reported crude estimates and child-years of follow-up, assuming a binominal (or Poisson) distribu-
tion. Heterogeneity between studies was assessed using I-squared (I2) statistics, and subgroup analysis was 
conducted to detect causes of heterogeneity. Weights were based on reported study population size, and 
data from multiple study sites were combined. However, estimates from countries with data available were 
only extrapolated to for the WHO region of those countries, and not individually for other countries in 
the same region. There were no data points on deaths in under-fives, most T1DM paediatric studies that 
reported deaths were in the age 0-14 years and did not provide breakdowns to allow extraction of deaths 
in under-fives. Based on published statistical evidence on chronic diseases, we assumed the prevalence of 
T1DM at any point in time to be about five times greater than the incidence [31]. In addition, based on 
the assumption of stable demographic changes in children aged 0-4 years globally, number of T1DM inci-
dent cases was extrapolated from the meta-estimates for the years 1990, 2010, and 2015 using the United 
Nations (UN) population projections [32]. All 
statistical analyses were conducted on STATA 
(Stata Corp V.15, College Station, Texas TX, 
USA). This study was conducted in line with 
the Preferred reporting items for systematic re-
views and meta-analyses (PRISMA) statement.
RESULTS
Literature search
A total of 27 627 records were identified 
through database searching (Medline 15 235, 
EMBASE 11 156 and Global Health 1236) and 
3 additional records were obtained from Goo-
gle Scholar, resulting in a total of 27 630 re-
cords analysed. After removing duplicates, 
15 329 records remained. Of these, 14 807 re-
cords were excluded, giving a total of 522 full-
text articles assessed for eligibility. Then, 439 
full-text articles were further excluded. A to-
tal of 83 studies were finally included for the 
analysis [10,11,13,17,19-23,33-106] (Figure 
1, and Table S4 in Online Supplementary 
Document).
Study characteristics
The numbers of studies conducted in declin-
ing order by decade were: 1990-1999 (36 
studies), 2000-2009 (28 studies), 1980-1989 
(14 studies), and 2010-2017 (5 studies). Most 
of the studies – 56 in total – were conduct-Figure 1. Flowchart of study selection.
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ed in the European region (EUR A-39, EUR B-14, 
EUR C-3). Eastern Mediterranean Region (EMR) 
contributed 11 studies, American region (AMR) 
8 studies, Western Pacific region 6 studies, while 
South East Asian (SEAR) and African regions (AFR) 
had only 1 study each. About two-thirds of select-
ed studies were rated as high-quality with most of 
these (70.5%) conducted in the European region. 
See Appendix S1 in Online Supplementary Doc-
ument for the full list of studies and study char-
acteristics.
Incidence rates of T1DM
The overall pooled incidence of T1DM in children 
aged 0-4 years globally is 11.2 (95% CI = 10.0-
12.3) per 100 000 child years. Heterogeneity was 
high across studies, with I2 estimated at 99.1%, P < 
0.000. The regional estimates showed that Europe-
an region had the highest pooled incidence, with 
EUR A leading all regions at 15.5 (95% CI = 13.5-
17.5) per 100 000 child years. However, EUR C had 
10.0 (95% CI = 6.5-13.6) per 100 000 child years, 
and EUR B 5.8 (95% CI = 4.7-7.0) per 100 000 
child years, ie, considerably lower rates. The Amer-
ican region also showed variation, with AMR A in-
cidence of 11.4 (95% CI = 7.8-14.9) and AMR B of 
2.5 (95% CI = 0.2-4.8) per 100 000 child years, respectively. High incidence rates were recorded in EMR 
B with 7.1 (95% CI = 4.2-10.0) and WPR A with 7.0 (95% CI = 2.9-11.0) per 100 000 child years, respec-
tively (Figure 2 and Figure 3).
When data points were categorised according to the study periods and re-analysed, an increasing trend of 
the T1DM incidence was observed (Figure 4 and Figure 5). The highest pooled incidence of T1DM was 
recorded in the years 2010-2015, with 20.9 (95% CI = 7.8-34.1) per 100 000 child years. This was pre-
ceded by the 2000-2009 study period, with an incidence rate of 13.2 (95% CI = 11.0-15.5) per 100 000 
child years. The years 1990-1999 and 1980-1989 showed pooled incidence of 10.0 (95% CI = 8.4-11.7) 
and 8.3 (95% CI = 5.1-11.6) per 100 000 child years, respectively. Using the United Nations population 
projection, and assuming demographic factors and differences between world regions were fully accounted 
for, these rates would amount to about 53 000 new cases in children aged 0-4 years in 1990, 62 000 new 
cases in 2000, 84 000 new cases in 2010, and 136 000 new T1DM cases in 2015, respectively. Given that 
very few deaths are identified in this age group (although the data on mortality in 0-4 year group are re-
markably scarce), the prevalence at any point in time should 
be expected to be about 5 times greater than the incidence, 
ie, to range from about 300 000 cases in 1990 to just under 
700 000 in 2015. Still, there is a very considerable uncertain-
ty about these estimates, with hardly any understanding of 
case-fatality rate in this period.
In order to speculate about the mortality from T1DM in the 
age group 0-4 years, we could apply historic mortality rates 
from the 19th century and early 20th century from USA 
and Scandinavian countries, which were in range of 1-4 per 
100 000 per child years - (these rates were relevant to the age 
group of 0-14 years).
If those rates were applied to the global child population aged 
0-4 years today, they would result in 6500 to 26 000 child 
deaths. However, given the near-certain fact that those deaths 
were predominantly occurring after year 4, and that there are 
treatment options currently available, it would be surprising 
Figure 2. Meta-estimate of the incidence rate of type 1 diabetes mellitus 
by WHO regions.
Figure 3. Box and whisker plot of the incidence rate of type 1 
diabetes mellitus by WHO regions.
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if the number of deaths in this period glob-
ally amounted to a four-digit number, rath-
er it would likely be measured in hundreds.
DISCUSSION
This study, to the best of our knowledge, pro-
vides the first systematically derived global 
and regional estimate of the incidence of type 
1 diabetes among children aged 0-4 years. 
Prior to the conduct of this study, there have 
been some efforts to describe the burden of 
T1DM in children globally, notably the WHO 
DiaMond project, which used standardized 
type 1 diabetes incidence registries world-
wide [11]. Despite using a capture-recapture 
method to ascertain completeness of regis-
try, one major limitation of this study was 
relative under-reporting and under-estima-
tion of most registries, especially in devel-
oping countries, where secondary sources of 
case ascertainment are largely unavailable. 
Indeed, few studies on the epidemiology of 
T1DM exists globally, most of these focus 
on clinical diagnosis and treatment, and are 
generally on adolescent populations [107]. 
In view of current reports suggesting an in-
creased prevalence or incidence in younger 
population groups [108], an understanding 
of the number of cases in children, especially 
under-fives, which this current study is pro-
viding, may be worthwhile.
In this study, the overall pooled incidence of 
T1DM in children aged 0-4 years globally in 
2015 was 20.9 (7.8-34.1) per 100 000 child 
years, accounting for about 136 000 T1DM 
cases. Our findings are higher than previous-
ly reported, and may further support recent 
reports that increasing incidence of T1DM is 
shifting towards younger age groups [108]. 
In the DiaMond study, a total of 19 164 
T1DM cases in children aged 0-14 years were 
identified in over 100 centres with age-ad-
justed incidence ranging from 0.1-36.8 per 
100 000/y [11].
A consistently increasing incident cases of T1DM was further observed over the study period, with about 
53 000, 62 000, 84 000, and 136 000 T1DM cases estimated in children aged 0-4 years in 1990, 2000, 
2010 and 2015, respectively. This finding, although significantly higher than previous estimates, is sup-
ported by many studies. In the WHO DiaMond study, between 1990 and 1994, the average increase in 
the incidence of T1DM was 2.4%, with this increasing to 3.4% the during the years 1995-1999. Patterson 
and colleagues predicted the global prevalence of T1DM will increase from 94 000 in 2005 to 160 000 in 
2020, with this likely doubling in children younger than five years [10]. Onkamo et al. also reported that 
the incidence of T1DM is increasing in low and high incidence populations, and that by the year 2010, 
the incidence in many other populations may be over 30 per 100 000/y [18].
Meanwhile, we observed our 2010 and 2015 estimates are higher than annual type 1 diabetes cases of 
77 880 and 96 100 in children 0-14 years reported by IDF in 2011 and 2017, respectively [109]. We be-
Figure 5. Incidence rate of type 1 diabetes mellitus by study period.
Figure 4. Meta-estimate of the incidence rate of type 1 diabetes mellitus by 
study period.
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lieve, this contrast, is due to our subgroup-analysis by study period, which clearly showed an increasing 
trend. Several authors have suggested that the global increase over the years in the incidence of T1DM 
may be due to better case ascertainment and registration process across many developing countries [2,13]. 
However, without a subgroup-analysis, our overall pooled estimate from all studies at 11.2 per 100 000 
would account for about 73 000 cases of T1DM in children under 5 years in 2015, which may not be too 
far from the IDF estimates.
From the regional estimates, the European region had the highest T1DM incidence rate with EUR A lead-
ing all regions at 15.5 (13.5-17.5) per 100 000 child years, and this is followed by the American region, 
with AMR A having 11.4 (7.8-14.9). According to the WHO DiaMond study, higher incidence rates of 
T1DM have been observed Europe and North America, mostly due to the fact that most registries in these 
regions have been established as far back as the 1980s, and are therefore better equipped to collate rela-
tively complete data on T1DM than other world regions [110]. As noted in the introduction, geographi-
cal and climatic factors may have also influenced distribution of mean incidence rates of T1DM globally 
[111,112]. Emerging evidence also suggests that environmental factors are now able to initiate the de-
velopment of T1DM in genotypes previously not known to be associated with the disease [2]. However, 
some experts have stated that geographical and environmental influences do not overtly account for the 
rapidly increasing incidence of T1DM [113,114].
As observed in this study, some studies have also noted that data from African and South East Asia are 
still relatively sparse, thus making the understanding of T1DM in the regions quite difficult [11,107]. 
These are therefore regions requiring further epidemiological surveys and research to contribute to bet-
ter understanding of T1DM globally.
This study could have been limited by a number of factors. However, one major constraint, which has al-
ready been reported in previous studies, is that most of the publications in this review were from the Eu-
ropean region. This implies that estimates may reflect more the conditions in these settings, and may not 
be generalizable to other world regions. Moreover, with Africa having only one study, it may be important 
to raise more awareness in this region on T1DM among children aged 0-4 years, especially to support ef-
forts (including availability of insulin) targeted at regions with very low national income, large child pop-
ulations and poor child health outcomes. Additionally, there were no studies that reported mortality and 
case fatality rates from T1DM in children aged 0-4 years, as this would have contributed significantly to 
the understanding of its epidemiology and instituting necessary intervention measures. Largely, type 1 
diabetes seems to be another major gap in global child health estimates. While the prevalence and inci-
dence patterns across many child populations appear to be unfolding, it still remains unclear if this would 
contribute to increase child mortality, especially in the 0-4 years age group. It is however certainly worth 
addressing in terms of morbidity and mortality in LMICs, as new information is beginning to emerge.
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